Kortokorezistentna Grejvsova orbitopatija – terapijske opcije
Medicinski glasnik
Reference
Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Front Endocrinol (Lausanne). 2020; 11: 1.
Men CJ, Kossler AL, Wester ST. Updates on the understanding and management of thyroid eye disease. Ther Adv Ophthalmol 2021; 13: 1–14. Kortokorezistentna Grejvsova orbitopatija – terapijske opcije 83
Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ dis
Sažetak
Kortokorezistentna Grejvsova orbitopatija – terapijske opcije
Preuzmi | Veličina |
---|---|
07_-_medicinski_glasnik_90_-_78-83_0.pdf (190.9 KB) | 190.9 KB |